Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure

Archives of Medical Science

Volumn 3, Issue 2, 2007, Pages 112-116

  Cocco, Giuseppe ^a,c   Chu, David ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b Cardiology Office   (Switzerland)

^c NONE   (Switzerland)

Author keywords

Diastolic heart failure; Natriuretic peptide; Weight reduction

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ALLOPURINOL; AMLODIPINE; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT;

ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; ECHOCARDIOGRAPHY; HEART FUNCTION; HUMAN; HYPERTENSION; MORTALITY; OBESITY; SODIUM BLOOD LEVEL; WEIGHT REDUCTION;

EID: 34547794180     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lang CC, Choy AM, Struthers AD. Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis. Clin Sci (Lond) 1992; 83: 519-527.
2. Tsutamoto T, Wada A, Maeda K, et at. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516.
3. Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 2004; 25: 292-299.
4. Reisin E, Frohlich ED, Messerli FH, et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983; 98: 315-319.
5. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000; 133: 92-103.
6. Cocco G, Pandolfi S, Rousson V. Sufficient Weight Reduction Decreases Cardiovascular Complications in Diabetic Patients with the Metabolic Syndrome. Heart Drug 2005; 5: 68-74.
7. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000; 101: 2118-2121.
8. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 1387-1393.
9. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 1998; 19: 990-1003.
10. Hamilton DM, Haennel RG. Validity and reliability of the 6-minute walk test in a cardiac rehabilitation population. J Cardiopulm Rehabil 2000; 20: 156-164.
11. Sharma R, Anker SD. The 6-minute walk test and prognosis in chronic heart failure- the available evidence. Eur Heart J 2001; 22: 445-448.
12. Enright PL. The six-minute walk test. Respir Care 2003; 48: 783-785.
13. Ingle L, Rigby AS, Carroll S, et al. Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 2007; 28: 560-568.
14. Hambrecht R, Gielen S, Linke A, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure. A randomized trial. JAMA 2000; 283: 3095-3101.
15. Giannuzzi P, Temporelli PL, Corrà U, Tavazzi L; ELVD-CHF Study Group. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the exercise in left ventricular dysfunction and chronic heart failure (ELVD-CHF) trial. Circulation 2003; 108: 554-559.
16. Conraads VM, Beckers P, Vaes J, et al. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004; 25: 1797-1805.
17. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28: 656-664.
18. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474-480.